Actualités Numinus Wellness Inc - NUMI | Actions Toronto Stock Exchange

Outils de qualité professionnelle, pour des investisseurs individuels.

Numinus Applies for Management Cease Trade Order

Numinus Applies for Management Cease Trade Order PR Newswire VANCOUVER, BC, Nov. 15, 2024 VANCOUVER, BC, Nov. 15, 2024 /PRNewswire/ - Numinus...

Numinus Wellness Announces Sale of Clinics and Unique Data Partnership to Increase Access to Mental Health Care

Numinus Wellness Announces Sale of Clinics and Unique Data Partnership to Increase Access to Mental Health...

Numinus Wellness Comments on FDA Decision on New Drug Application for MDMA-Assisted Therapy for PTSD

Numinus Wellness Comments on FDA Decision on New Drug Application for MDMA-Assisted Therapy for PTSD PR...

Numinus Wellness Inc. Announces Third Quarter Fiscal 2024 Results

Numinus Wellness Inc. Announces Third Quarter Fiscal 2024 Results PR Newswire VANCOUVER, BC, July 11, 2024 Q3...

Numinus to Host Q3 Fiscal 2024 Results Conference Call on July 11, 2024

Numinus to Host Q3 Fiscal 2024 Results Conference Call on July 11, 2024 PR Newswire VANCOUVER, BC, July 10...

Numinus Wellness Announces Resignation of Director

Numinus Wellness Announces Resignation of Director PR Newswire VANCOUVER, BC, June 24, 2024 VANCOUVER, BC...

MedBright AI Announces Strategic Acquisition by Numinus Wellness

Plans name change to “Numinus Intelligence” leveraging its current revenue generating operations to AI-enable...

Numinus Wellness Comments on FDA Advisory Committee Meeting for Investigational MDMA-Assisted Therapy for PTSD

Numinus Wellness Comments on FDA Advisory Committee Meeting for Investigational MDMA-Assisted Therapy for...

Numinus Wellness Announces Voting Results From its Annual General Meeting of Shareholders

Numinus Wellness Announces Voting Results From its Annual General Meeting of Shareholders PR...

Numinus Wellness Receives Health Canada Approval for Study into Group Model for MDMA-Assisted Therapy

Numinus Wellness Receives Health Canada Approval for Study into Group Model for MDMA-Assisted Therapy PR...

Numinus Wellness Focused on Boosting Profitability and Expanding Community Support

Numinus Wellness Focused on Boosting Profitability and Expanding Community Support PR Newswire VANCOUVER, BC...

Cedar Clinical Research selected as clinical research site for Cybin's Phase 3 Study of CYB003

Cedar Clinical Research selected as clinical research site for Cybin's Phase 3 Study of CYB003 PR...

Numinus Wellness Provides Corporate Update

Numinus Wellness Provides Corporate Update PR Newswire VANCOUVER, BC, April 15, 2024 Numinus sharpens its...

Numinus Wellness Inc. Announces Second Quarter Fiscal 2024 Results

Numinus Wellness Inc. Announces Second Quarter Fiscal 2024 Results PR Newswire VANCOUVER, BC, April 12, 2024...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

	Prix en temps réel	Carnet d'ordres
BATS Europe
Chi-X Europe
Euronext

	Prix en temps réel	Carnet d'ordres
BATS Europe
Chi-X Europe
Euronext

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Numinus Wellness Inc (NUMI)

Outils de qualité professionnelle, pour des investisseurs individuels.

NUMI Actualités

Numinus Applies for Management Cease Trade Order

Numinus Wellness Announces Sale of Clinics and Unique Data Partnership to Increase Access to Mental Health Care

Numinus Wellness Comments on FDA Decision on New Drug Application for MDMA-Assisted Therapy for PTSD

Numinus Wellness Inc. Announces Third Quarter Fiscal 2024 Results

Numinus to Host Q3 Fiscal 2024 Results Conference Call on July 11, 2024

Numinus Wellness Announces Resignation of Director

MedBright AI Announces Strategic Acquisition by Numinus Wellness

Numinus Wellness Comments on FDA Advisory Committee Meeting for Investigational MDMA-Assisted Therapy for PTSD

Numinus Wellness Announces Voting Results From its Annual General Meeting of Shareholders

Numinus Wellness Receives Health Canada Approval for Study into Group Model for MDMA-Assisted Therapy

Numinus Wellness Focused on Boosting Profitability and Expanding Community Support

Cedar Clinical Research selected as clinical research site for Cybin's Phase 3 Study of CYB003

Numinus Wellness Provides Corporate Update

Numinus Wellness Inc. Announces Second Quarter Fiscal 2024 Results

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Vendredi fou

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Numinus Wellness Inc (NUMI) Actualités

Numinus Wellness Inc (NUMI)

Outils de qualité professionnelle, pour des investisseurs individuels.

NUMI Actualités

Numinus Applies for Management Cease Trade Order

Numinus Wellness Announces Sale of Clinics and Unique Data Partnership to Increase Access to Mental Health Care

Numinus Wellness Comments on FDA Decision on New Drug Application for MDMA-Assisted Therapy for PTSD

Numinus Wellness Inc. Announces Third Quarter Fiscal 2024 Results

Numinus to Host Q3 Fiscal 2024 Results Conference Call on July 11, 2024

Numinus Wellness Announces Resignation of Director

MedBright AI Announces Strategic Acquisition by Numinus Wellness

Numinus Wellness Comments on FDA Advisory Committee Meeting for Investigational MDMA-Assisted Therapy for PTSD

Numinus Wellness Announces Voting Results From its Annual General Meeting of Shareholders

Numinus Wellness Receives Health Canada Approval for Study into Group Model for MDMA-Assisted Therapy

Numinus Wellness Focused on Boosting Profitability and Expanding Community Support

Cedar Clinical Research selected as clinical research site for Cybin's Phase 3 Study of CYB003

Numinus Wellness Provides Corporate Update

Numinus Wellness Inc. Announces Second Quarter Fiscal 2024 Results

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Vendredi fou

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres